Frequent drug interactions in general practice;Hyppige lægemiddelinteraktioner i almen praksis

Ugeskrift for Laeger

Volumn 166, Issue 39, 2004, Pages 3401-3404

  Bjerrum, Lars ^a   Andersen, Morten ^a   Petersen, Gert ^a   Kragstrup, Jakob ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANGIOTENSIN II ANTAGONIST; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CIMETIDINE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISULFIRAM; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; LAMOTRIGINE; LITHIUM; METHOTREXATE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENICILLIN G; PHENOBARBITAL; RECOMBINANT HUMAN INSULIN; SEROTONIN UPTAKE INHIBITOR; SULFONAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; DRUG;

ARTICLE; DRUG INFORMATION; POLYPHARMACY; ADULT; AGED; DENMARK; DRUG INTERACTION; GENERAL PRACTICE; HUMAN; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; RISK FACTOR; STATISTICS;

ADULT; AGED; DENMARK; DRUG INTERACTIONS; FAMILY PRACTICE; HUMANS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; POLYPHARMACY; RISK FACTORS;

EID: 6044246057     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hartshorn EA. Drug interactions. Fam Community Health 1982;5:45-57.
2. Avery GS. Drug interactions that really matter: a guide to major importance drug interactions. Drugs 1977;14:132-46.
3. Hallas J, Gram LF, Grodum E et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmacol 1992;33:61-8.
4. Gronroos PE, Irjala KM, Huupponen RK et al. A medication database - a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol 1997;53:13-7.
5. Tamai IY, Strome LS, Marshall CE et al. Analysis of drug-drug interactions among nursing home residents. Am J Hosp Pharm 1989;46:1567-9.
6. Rosholm JU, Bjerrum L, Hallas J et al. Polypharmacy and the risk of drug-drug interactions among Danish elderly. Dan Med Bull 1998;45:210-3.
7. Merlo J, Liedholm H, Lindblad U et al. Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. BMJ 2001;323:427-8.
8. Rønning M, Sakshaug S, eds. Guidelines for ATC classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2002.
9. Bjerrum L. Pharmacoepidemiological studies of polypharmacy. Methodological issues, population estimates and influence of practice patterns [ph.d.-af-handl]. Odense: Syddansk Universitet, 1998.
10. Hansten PD, Horn JR. Drug interactions & updates quarterly. United States: Applied Therapeutics, Inc., 2002.
11. Stata Press. Stata for windows. Texas: Stata Statistical Software, 1999.
12. Hartshorn EA. Drug interactions. Fam Community Health 1982;5:45-57.
13. Hallas J, Nissen A. Individualized drug utilization statistics. Eur J Clin Pharmacol 1994;47:367-72.
14. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000;56:501-9.
15. Bjerrum L, Rosholm JU, Hallas J et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol 1997;53:7-11.
16. Gaist D, Sørensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
17. Tamblyn RM, McLeod PJ, Abrahamowicz M et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Can Med Assoc J 1996;154:1177-84.
18. Petrie JC, Howie JG, Durno D. Awareness and experience of general practitioners of selected drug interactions. BMJ 1974;2:262-4.
19. Bjerrum L, Bergman U. Wide variation in the number of different drugs prescribed by general practitioners. Scand J Prim Health Care 2000;18:94-8.